Condition
Chronic Kidney Disease Mineral and Bone Disorder clinical trials and research
As of November 12, 2026, Find a Trial lists 5 Chronic Kidney Disease Mineral and Bone Disorder clinical trials that are recruiting, at sites in 3 countries (most in Denmark (3), United States (1), China (1)). By phase: Phase 4 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 3Countries
Newest Chronic Kidney Disease Mineral and Bone Disorder clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Phosphate assessment in people with chronic kidney disease | — | Dallas, Texas | Recruiting | Jan 27, 2026 |
| CKD-MBD: Bone and Mineral Health in Adults with Advanced CKD | — | Herlev | Recruiting | Sep 25, 2025 |
| Regulating parathyroid hormone to improve bone mineral density in people with advanced chronic kidney disease | — | Herlev, Capital Region | Recruiting | Sep 12, 2025 |
| Integrated diagnosis and treatment for chronic kidney disease outcomes | — | Beijing, Beijing Municipality | Recruiting | Feb 16, 2022 |
| Using parathyroid hormone to treat bone disorder in kidney disease patients | Phase 4 | Aalborg and 3 other locations | Recruiting | Aug 21, 2020 |
All recruiting trials (5)
-
Phosphate assessment in people with chronic kidney disease
This study will test how increasing dietary phosphate over three weeks affects blood and urine markers in adults with and without stage 3–4 chronic kidney disease.
-
CKD-MBD: Bone and Mineral Health in Adults with Advanced CKD
This study follows adults with advanced CKD to see how bone and mineral markers relate to kidney function and potential fracture risk.
-
Regulating parathyroid hormone to improve bone mineral density in people with advanced chronic kidney disease
This study will try lowering high parathyroid hormone with activated vitamin D or calcimimetics to see if bone mineral density improves in people over 50 with advanced chronic kidney disease.
-
Integrated diagnosis and treatment for chronic kidney disease outcomes
This study is trying to see if a combined approach to diagnosing and treating chronic kidney disease can help patients manage their health better and improve their overall outcomes.
-
Using parathyroid hormone to treat bone disorder in kidney disease patients
This study is testing whether a hormone treatment can help improve bone health and reduce fracture risk in patients with chronic kidney disease.
Related topics
Quick answers
How many Chronic Kidney Disease Mineral and Bone Disorder clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in Denmark (3 trials), United States (1 trial), China (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 4: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.